Abvc Biopharma, Inc.ABVC
Price (close)
$1.13
Market cap
$30.1M
P/E
—
Revenue (TTM)
$296,000
Net income
-$7.1M
Dividend yield
—
1-year total return
-63.8%
Net margin
—
Revenue growth
—
Debt / equity
0.01x
What Abvc Biopharma, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $483,045 | $355,797 | $969,783 | $152,430 | $509,589 | $296,000 |
| Net income | -$10.6M | -$12.8M | -$16.4M | -$7.8M | -$4.9M | -$7.9M |
| Free cash flow | — | -$7.6M | -$7.5M | -$4.2M | — | — |
More on ABVC.
- Abvc Biopharma, Inc. summary
- Abvc Biopharma, Inc. financial statements
- Abvc Biopharma, Inc. key metrics
- Abvc Biopharma, Inc. health scores and style box
- Abvc Biopharma, Inc. earnings
- Abvc Biopharma, Inc. dividends
- Abvc Biopharma, Inc. valuation
- Abvc Biopharma, Inc. ownership and insiders
- Abvc Biopharma, Inc. peers
Figures from Abvc Biopharma, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.